A 2-year retrospective study of the treatment of retinal vein occlusion with dexamethasone 0.7 mg intravitreal implant (Ozurdex®): an emphasis on combination therapy.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.